These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21814597)

  • 1. Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal Tumors.
    Jung SH; Suh KS; Kang DY; Kang DW; Kim YB; Kim ES
    Gut Liver; 2011 Jun; 5(2):171-80. PubMed ID: 21814597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 3. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
    Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
    Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.
    Li J; Zhang H; Lu Y; Chen Z; Su K
    Int J Clin Exp Pathol; 2015; 8(5):5721-6. PubMed ID: 26191287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
    West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
    Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.
    Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM
    Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors.
    Abdel-Hadi M; Bessa SS; Hamam SM
    J Egypt Natl Canc Inst; 2009 Sep; 21(3):237-47. PubMed ID: 21132034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16 overexpression in BRAF-mutated gastrointestinal stromal tumors.
    Shi SS; Wang X; Xia QY; Rao Q; Shen Q; Ye SB; Li R; Shi QL; Lu ZF; Ma HH; Zhou XJ
    Expert Rev Mol Diagn; 2017 Feb; 17(2):195-201. PubMed ID: 28034324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
    Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
    J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B; Hornick JL; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
    Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
    Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
    [No Abstract]   [Full Text] [Related]  

  • 15. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.
    Medeiros F; Corless CL; Duensing A; Hornick JL; Oliveira AM; Heinrich MC; Fletcher JA; Fletcher CD
    Am J Surg Pathol; 2004 Jul; 28(7):889-94. PubMed ID: 15223958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).
    Miwa S; Nakajima T; Murai Y; Takano Y; Sugiyama T
    J Gastroenterol; 2008; 43(7):531-7. PubMed ID: 18648740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
    Sui XL; Wang H; Sun XW
    Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis value of CD117 and PDGFRA, alone or in combination DOG1, as biomarkers for gastrointestinal stromal tumors.
    Xu C; Han H; Wang J; Zhang B; Shao Y; Zhang L; Wang H; Wang H; Wu Y; Li X; Li R; Tian Y
    Ann Transl Med; 2015 Nov; 3(20):308. PubMed ID: 26697468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
    Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
    BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.